Four of 38 patients with non-Hodgkin’s lymphoma have seen the disease disappear following treatment, while five others saw reductions of 50 per cent in their tumours.

While the trials were only carried out on patients with blood cancer, it is hoped the methods can be adapted to tackle other cancers.

The drug, which could prove cheaper than other similar therapies, works by activating the body’s own defences to attack the cancer.

The results have been described as an “exciting” and “significant” development in the use of immunotherapy, the process of using the body’s own immune system to fight disease.

Health Care
You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.